Morphological evaluation of the liver continues to play a central role for the diagnosis, grading and staging of chronic viral hepatitis. The defining morphology is necroinflammation, that is hepatocyte injury and inflammation. Hepatocyte injury is usually irreversible, and presents as apoptosis and/or necrosis. Mononuclear cell infiltration of the portal tracts, that is usually accompanied by periportal (interface) and lobular inflammation is typical. Continued necroinflammatory activity at the limiting plate destroying periportal parenchyma initiates fibrogenesis leading to cirrhosis. Fibrosis can be reversible with fragmentation of scar tissue, resolving vascular derangements and parenchymal regeneration. Grading is a measure of the intensity of necroinflammatory activity and staging is a measure of fibrosis and architectural alteration. Besides staging, Laennec scoring system, subdividing cirrhosis that is based on histologic parameters of fibrous septa width and number, has been advised to be used in reporting chronic viral hepatitis.
Introduction
Chronic hepatitis (CH) is defined as persistence of liver injury with raised aminotransferase levels and/or viral markers for more than 6 months [1, 2] . This definition is actually imperfect, because acute self-limiting hepatitis may prolonge more than 6 months and CH may have an acute onset [1, 3] . On the other hand, the term CH is often restricted to a limited number of causes, but many liver diseases have an inflammatory component (Table I) [1] . Thus, morphological evaluation of the liver continues to play a central role for the diagnosis of CH and its differentiation from acute hepatitis and other inflammatory diseases of the liver [4, 5] . this classification has often been misinterpreted as aiming at differentiation between separate disorders rather than just different grades of severity of the same disease process. Since this initial classification, there has been impressive progress in the understanding of CH including recognition of various causes, pathogenesis and different therapy options. In 1994, two international working parties recommended a predominantly etiological classification, that is supplemented by a semiquantitative scoring [7] . Thus, there is a need for liver biopsy in patients with CH in order to establish the diagnosis, to guide the management by considering the severity of hepatitis (grading), the extent of progression to cirrhosis (staging) and also to determine possible additional pathologic processes (Table II) [1, 3, 4] . 
General Pathology of Chronic Viral Hepatitis
The morphologic pattern of chronic hepatitis is not spesific for viral hepatitis and may be seen in variety of conditions (Table I) [1, 2] . The defining morphology of chronic hepatitis of any cause is necroinflammation, that is hepatocyte injury and inflammation. Hepatocyte injury is usually irreversible, and presents as apoptosis and/or necrosis. Depending on the etiology, reversible injury such as ballooning degeneration, hepatocellular cholestasis and steatosis, can also be seen. All cases of chronic viral hepatitis (CVH) are distinguished by mononuclear cell infiltration of the portal tracts (portal inflammation), that is usually accompanied by periportal (interface) and lobular inflammation. Distribution and density of inflammatory cells may vary from case to case or even in sequential biopsies from the same patients [1, 4, 5, 8] .
Portal Inflammation
The portal tracts may be of normal size or appear widened by the influx of mononuclear cells. The infiltrate includes predominantly CD4+helper/inducer T-lymphocytes with an admixture of plasma cells. In some portal tracts, macrophages containing necrotic hepatocyte debri (diastase resistant, periodic acid-Schiff positive material) can be a component of inflammation. Scattered eosinophils and neutrophils may be present. Lymphoid aggregates or fully formed follicles, although typical for hepatitis C, can also be seen in all forms of viral hepatitis. Inflammation may encroach on the bile ducts, particularly in hepatitis C, leading to damage or even destruction [5, 8, 9] .
Interface Hepatitis
It is an inflammation and apoptosis affecting the hepatic parenchyma that is in contact with the mesenchymal stroma of the portal tracts (interface). At the interface FAS-ligand positive CD8+ suppressor/cytotoxic T-cells predominate and lead to apoptosis in hepatocytes forming the limiting plate. Besides apoptosis, hepatocytes in areas of piecemeal necrosis often undergo balloning degeneration, appear pale and swollen, with clumping of cytoplasm. Referring to the way in which the limiting plate was eroded, morphologic appearance is also termed as "piecemeal necrosis" ( Figure  1 ). The term interface hepatitis is now often preferred, because there is evidence to suggest that apoptosis rather than necrosis may be involved in the periportal areas [1, 5, 9, 10] . 
Lobular Necroinflammation
Hepatocyte apoptosis/necrosis in CVH is variable in severity and it is associated with monunuclear cell response. Isolated apoptotic hepatocytes (acidophilic bodies) can be scattered throughout the lobule. When monunuclear inflammatory cells cluster around injured hepatocytes (either apoptotic or necrotic), it is termed as spotty (focal) necrosis ( Figure  2 ). Kupffer cells in the areas of spotty necrosis may contain phagocytosed cellular debris. Larger areas of hepatocyte loss (area occupied more than five hepatocytes) are referred to as confluent necrosis. Confluent necrosis and collaps that links terminal hepatic venules to portal tracts are termed as bridging necrosis (Figure 3 ). Panlobular necrosis is rare in CVH. The severity of lobular necroinflammation correlates with the accumulation of progenitor cells in the area of necrosis [2, 3, 5, 9, 10] . Other parenchymal changes seen in CVH include ballooning degeneration, steatosis, oncocytic change, and iron deposition. Ballooning degeneration of hepatocytes may be seen in exacerbations of CVH and can be accompanied by zone 3 bilirubin stasis. Steatosis, although more common in hepatitis C, can also be seen in B and D virus infection ( Figure 2 ). The mechanism for the steatosis may be interference by the viral core protein with lipoprotein assembly and secretion. It is accepted as a risk factor for progression and can interfere therapy. Oncocytic change is due to accumulation of large numbers of closely-packed mitochondria in hepatocytes, with uncertain significance. Siderosis is also more common in hepatitis C, and it influences the progression of liver injury. Iron deposition is not only seen in hepatocytes, but also in macrophages, endothelial cells and portal tracts [1, 3, 4] .
Fibrosis
In the liver, there is dynamic production and degradation of extracellular matrix at all time points. Development of scarring in a chronically diseased liver is actually the result of a balance in favor of matrix deposition. Continued necroinflammatory activity at the limiting plate (interface) destroying periportal parenchyma initiates fibrogenesis in CVH and periportal parenchyma is gradually replaced by fibrous tissue leading to stellate enlargement of the portal tracts ( Figure 4A ). Portal-portal fibrous septa is the result of linkage of adjacent fibrotic portal tracts [11] . Episodes of severe lobular necroinflammatory activity involving zone 3 ends up with the formation of portal-central fibrous septa (bridging fibrosis) ( Figure 4B ) [12, 13] . Fibrogenesis in the liver causes vascular rearrangement, increased capillary resistance and shunts (arterio-venous and portal-systemic) leading to ischemic changes of the parenchyma. Continued periportal/periseptal necroinflammation and additional ischemic changes accelerates fibrogenesis leading to cirrhosis, which is usually macronodular or mixed microand macronodular in type [14, 15] . Reliable evaluation of fibrosis, that is collagen deposition, requires connective tissue stains, such as Masson's trichrome stain. In H&E stained sections, the degree of fibrosis is often underestimated [8, 9, 12, 13] . Collagen immunohistochemistry (IHC) stains, mainly collagen type V and VI, may be helpful in the early stages of fibrosis, when trichrome is weak or negative [16] . 
Cirrhosis
Cirrhosis by definition is diffuse nodularity of the liver, caused by extracellular matrix deposition leading to parenchymal nodules. The histologic criteria for a diagnosis of cirrhosis are summarized in Table III [1] . In liver biopsies, when there are well-defined rounded nodules surrounded by fibrous septa, the diagnosis is easily established. However, a slender core from within a large cirrhotic nodule can be difficult to identify. In addition, a nodular appearance beneath the liver capsule is not representative of the whole liver and is due to normal septa extending from the liver capsule. So, the ease with which the pathologist can diagnose cirrhosis from biopsy, depends on the size of the biopsy, the type of the biopsy needle used and the area of the liver biopsied. Subcapsular biopsies, thin, and small biopsies are inadequate for the accurate diagnosis of cirrhosis [1, 5, 14, 17] . 
Regression of Fibrosis and Cirrhosis
In 2000, Wanless et al documented regression of fibrosis on the sequential biopsies from a CVH-B patient with successful anti-viral therapy [18] . It has now been demonstrated that, in all forms of CVH, fibrosis can regress with elimination of viral activity and infection. Morphologic features of regression, termed as "hepatic repair complex", were described by Wanless et al. Fragmentation-regression of scar (perforated septa, isolated thick collagen fibers, delicate periportal fibrous spikes, hepatocytes within splitting septa), resolving vascular derangements (portal tract remnants, hepatic vein remnants) and parenchymal regeneration (hepatocyte buds) comprise the regenerative phenomena in the liver [18, 19] . 
Histopathology of Specific Types of Chronic Viral Hepatitis

Chronic Viral Hepatitis B (CVH-B)
Both "ground-glass" hepatocytes and "sanded" nuclei are important morphologic clues for hepatitis B infection. Ground-glass appearence in H&E-stained sections is due to accumulation of hepatitis B surface antigen (HBsAg) in the cytoplasm of hepatocytes ( Figure 5 ). There is a finely granular appearance of the central part of the cytoplasm that is sorrounded by a pale halo. The differential diagnosis of ground-glass hepatocytes includes oncocytic change, drug-induced hypertrophy of the endoplasmic reticulum and from inclusion containing hepatocytes in cyanamide toxicity, Lafora's disease and fibrinogen storage disease. The morphology in liver biopsy in CVH-B depends on the phase (immunotolerant, immune-clearance, or non-replicative) of the hepatitis B virus infection. In immunotolerant phase, although the degree of histologic activity varies, low levels of necroinflammation are more common. Both interface and lobular activity may be seen. Ground-glass hepatocytes and sanded nuclei are abundant and diffuse in distribution. During immune clearance phase, histologic activity is typically high and ground-glass hepatocytes and sanded nuclei are rare. In non-replicative phase, there is low activity with minimal interface hepatitis. Lobular necroinflammation is not necessarily accompanied by portal and periportal inflammation. Ground-glass hepatocytes may be aggregated in focal accumulations [1, 2, 3, 5] . Hepatitis B DNA viral load is related with both degree of necroinflammation and fibrosis [21] . Reactivation of virus replication and histologic activity are common and sometimes associated with the emergence of viral mutants. In these cases, in spite of the negative HBeAg and presence of anti-HBe, histologic activity is unexpectedly high [1, 2, 5, 22] .
Chronic Viral Hepatitis B+D (CVH-B+D):
Presence of Delta virus is associated with relatively high necroinflammation. Sanded nuclei may be seen and HBcAg can be demonstrated within the nuclei of hepatocytes by immunohistochemical stains [1, 2, 3] .
Chronic Viral Hepatitis C (CVH-C):
In CVH-C, necroinflammation is usually milder than other types of CVH. The presence of steatosis, portal lypmpoid aggregates/follicles, and bile duct damage is suggestive of, but not diagnostic for, CVH-C ( Figure 6 ) [1, 5, 23] . 
Chronic Viral Hepatitis : Grading and Staging
The purpose of histological scoring (grading and staging) systems is to record histological features which are thought to indicate the severity and progression of CVH. Grading is a measure of the intensity of necroinflammatory activity that includes assessment of portal, periportal and intraacinar inflammatory cell infiltration and various forms of liver cell damage/necrosis. Staging, on other hand, is a measure of fibrosis and architectural alteration [1,2,5,24].
Knodell et al. designed the first formal scoring system, Histologic Activity Index (HAI), specifically for the study of chronic hepatitis, in order to follow the course of asymptomatic patients in whom conventionally used clinical features could not be evaluated [25] . HAI, was based on four components: 1) periportal and bridging necrosis (0-10), 2) intralobular degeneration and focal necrosis (0-4), 3) portal inflammation (0-4), and 4) portal fibrosis (0-4). In a liver biopsy, numerical values alloted for each of these components are added in order to obtain the HAI score (range: 0-22) (Table IV) [25] . A number of criticism have been made for the Knodell HAI scoring system and can be summarized as: 1) discontinuous scale (0,1,3,4) is used for each histological features assessed, 2) scores for portal inflammation involve combining assessments relating to the density within an individual portal area and the overall proportion of the portal tracts involved, which can be misleading in small biopsies, 3) it combines interface hepatitis with bridging necrosis, the latter is accepted as a manifestation of lobular activity and should be assessed separately, 4) scores of activity are combined with scores for fibrosis [26] . In recognition of these problems, Ishak and colleagues modified Knodell system in 1995 (Tables V and VI) [27] . The system proposed by Ishak et al. incorporates current concepts relating to the pathogenesis of liver damage in CVH by providing a wide range of possible scores (Tables V and VI) [27] . Simplified scoring systems, such as Scheuer [28] , Batts/ Ludwig [29] and METAVIR [30] , are notable among the several other scoring systems and may be more appropriate to use in daily pathology practice (Tables VII and VIII) . These systems do not score portal inflammation in line with the conviction that regardless of severity of portal inflammation, in absence of interface hepatitis, coincides with low risk of fibrosis [1, 5, 26] . METAVIR system, designed by French pathologists in CVH-C patients, uses an algorithmic approach to determine necroinflammatory score [30] . An important feature of these systems recognized that grading of necroinflammatory activity should be seperated from staging. The main criticism to these simplified systems is the production of a narrower range of potential scores, which limits their usefulness in the context of monitoring response to therapy in clinical trials [5, 26] .
As some of them mentioned above, each of these systems has special strenghts and weaknesses, but in all of them there is a fundamental problem. That is, assessment scores of each individual categories of necroinflammation, which may have different pathogenetic mechanisms and prognostic significance, are added together. The total score generated do not represent measurements of a continuous variable, and cannot be regarded as mathematically valid (Figure 7 ) [26] . Besides, there are problems of inter-observer variation which stem partly from imprecise terminology defining individual histological features [31, 32] . In general, in each of the scoring systems used, better reproducibility has been obtained for scoring fibrosis than for scoring necroinflammation (31) . In a study to identify the sources of variability, the level of experience was found to have more influence on agreement than the characteristics of the specimen [32, 33] . Evaluation of the liver biopsy by an experienced liver pathologists is important in order to design the therapy in a CVH patient [33] . 
Staging Cirrhosis
Cirrhosis has been widely regarded as an irreversible end-stage liver disease. However, recent studies have demonstrated with serial liver biopsies that fibrosis may also decrease with time in some cirrhotic livers [18] . Specific morphological changes that are associated with irreversibility include: thickness of collagen bands, elastinrich scars, matrix modification with cross linking (the type of collagen deposition), the loss of hepatocytes that limit regeneration and loss of cells that drive matrix turnover from the septa combined with vascular extinction [17] . Since various clinical stages do exist and regression of fibrosis can be detected in cirrhotic patients, further subclassification of histology of cirrhosis seems necessary [17, 18] . For semiquantitative estimation, Laennec Staging System, that is based on histologic parameters of fibrous septa width and number has been proposed ( Figure 8 ) [34] . The Laennec system subdivides the highest fibrosis stage of 4 (in 4-tier systems) as 4A, 4B, and 4C in order to recognize the variable distribution, maturation and amount of fibrosis in cirrhotic livers (Table VIII) [34] . Histologic subclassification of cirrhosis by the Laennec Staging System have been shown to be tightly correlated with both the clinical stage of cirrhosis and grade of portal hypertension [34] [35] [36] [37] . 
Differential Diagnosis
Morphologic differentiation of CVH from acute hepatitis depends on the presence of fibrosis in CVH. While the parenchymal changes predominate in acute hepatitis, especially in perivenular areas, portal and periportal changes predominate in CVH. Bridging necrosis that can be seen in both acute and chronic hepatitis may be mistaken for bridging septa of CVH. This problem can be solved by elastic stains, such as Victoria blue, which is negative in acute, but positive in mature septa of CVH [1, 3, 4] .
Any disease leading to dense lymphoplasmocytic infiltrate in the portal tracts may mimic CVH, such as autoimmune hepatitis, primary biliary cirrhosis(PBC), drug induced liver diseases and lymphomas [1] [2] [3] [4] [5] . Cases of CVH (mainly CVH-C) with antinuclear antibody (ANA) positivity may also mimic autoimmune hepatitis, clinically [38, 39] . As a rule CVH-C lacks the prominent plasma cell infiltrate and severe necroinflammatory activity typically seen in autoimmune hepatitis, but the differential diagnosis
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can be difficult in some cases [1] . Early lesions of PBC may mimic CVH. Destruction and/or loss of bile ducts, cholate stasis and accumulation of copper-associated protein in periportal hepatocytes suggest biliary disease [3] . Drugs sometimes cause confusion in the diagnosis, but with clinical correlation and laboratory findings this issue can easily be solved [1, 2, 5] . Lymphoma or leukemic infiltrates may also mimic CVH, particularly when the infiltrate is most predominantly located in the portal tracts. In these cases monomorphism and marked atypia of inflammatory cells favor lymphoma/leukemia [2] .
Adequacy of Liver Biopsy
Ideal length of a liver biopsy is 3.0 cm and it must be obtained with a 16 gauge needle. If cirrhosis is suspected, a cutting needle rather than a suction needle should be used [40, 41] . In CVH, accuracy in grading and staging is reduced in biopsies less than 2.0 cm in lenght, and needle biopsy specimens measuring less than 1.5 cm in lenght are accepted as unreliable to determine grade and stage of CVH [42] [43] [44] . If the lenght of liver biopsy is less than 1.5 cm and/or liver biopsy contains less than 11 complete portal areas, it must be noted in the pathology report, and the clinicians must recognize that the diagnosis, grading and staging may be incorrect due to an insufficient sample size [40, 41] . A biopsy with adequate size represents only one hundred thousandth of the whole liver, and sampling variability appears to be a limitation in scoring CVH [45] . In CVH patients biopsies taken from left and right liver lobe showed discordant results in 33% of the cases by at least one histologic stage. In smaller biopsies this discordance was by at least two stages [46] .
Key Points
• Necroinflammation determined as hepatocyte injury and inflammation is the main pathology of chronic viral hepatitis.
• Continued necroinflammatory activity at the limiting plate destroying periportal parenchyma initiates fibrogenesis leading to cirrhosis.
• Grading is a measure of the intensity of necroinflammatory activity and staging is a measure of fibrosis and architectural alteration
• Fibrosis can be reversible with fragmentation of scar tissue, resolving vascular derangements and parenchymal regeneration
